Followers | 435 |
Posts | 57599 |
Boards Moderated | 5 |
Alias Born | 01/09/2007 |
Friday, August 31, 2018 10:05:32 AM
what is missed is the *fact* that when retail sells out .. volume increases .. it doesn't decrease
which is why *volume* actually matters .. *volume* is comprised of trades .. which reveal
exactly what is done and when .. documentation also reveals decoys (MMs' utilized by NR entity)
like OTCX who signs on to block on the ask and/or UC on the ask .. but never adjusts the size of
their *bid* .. documentation of NRs' bogus bs helps for those wishing to file complaints .. NR counts
on an unsophisticated investor being clueless ..
so as angst producing as it clearly is to non retail embedded (2009/2010) .. PTOI (stock) remains
an OTC Survivor @ the EO August 2018 .. 5 years after P2O was wrested back
for almost 4 of those years .. PTOI (stock) has been held at 6c or below .. (October 2014 ACC Executive
Summary) .. for almost 5 years (EO December 2013) PTOI (stock) has been held at 10c or below .. there
will be *impact* on any company's ability to execute with a severely compressed PPS .. which is why it's done
(goal is to force P2O .. company .. into toxic financing) .. which almost always entails a blown out I/O .. which is
then shorted against .. and so the cycle goes until stock is @ .000s
what is so unique about P2O .. company .. is that that hasn't happened .. as I've noted previously suspect after
the *obvious* of 2012/2013 .. current CEO has an issue of *trust* .. which is why it's been so *imo* revealing who
has infused monies since 2016 ..
what is equally revealing is that so many actual P2O investors have drawn their respective lines in the sand re: their PTOI *shares*
anyone who wanted out .. *imo* has been long gone for years (2014)
4kids
10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM